Corcept Therapeutics logo

Senior Director, Postmarketing Safety Operations Lead

Corcept Therapeutics

Redwood City, CAOnsitePosted 24 days ago$238,400 - $315,600/year
Full TimeDirector & AbovePharmacovigilance / Drug SafetyPharmaceutical
Original posting ↗

Summary

As Corcept's portfolio and international presence continue to expand, the Patient Safety & Pharmacovigilance (PSPV) organization is expanding its capabilities to support the company's growing portfolio of innovative medicines. We are seeking a talented and experienced leader to serve as Senior Director, Postmarketing Safety Operations Lead and provide strategic and operational leadership for global postmarketing safety operations.

Job description

The function includes two complementary areas: Case Management Operations, Postmarketing Safety and External Engagement, Postmarketing Safety.

The Senior Director will provide strategic and operational leadership across global postmarketing safety case management and external safety-data channels, including case management vendors, specialty pharmacies, hubs, patient support programs, and other external partners. The role will build and scale the operating model, drive operational excellence, vendor performance, data quality, and continuous improvement, and develop the capabilities needed to support Corcept's expanding commercial and international footprint.

As a member of the PSPV Leadership Team, this leader will work closely across PSPV (Medical Safety, Safety Sciences, Epidemiology, Clinical Trial Patient Safety, Safety Systems, Business Operations, and QPPVs), as well as Commercial, Medical Affairs, Regulatory Affairs, Quality, and other functions across Corcept.

Responsibilities

  • Lead global postmarketing safety operations supporting Corcept's marketed-product portfolio
  • Lead and develop the Case Management Operations and External Engagement functions, establishing a cohesive global operating model
  • Provide strategic oversight of global outsourced ICSR processing and vendor performance
  • Establish effective operational processes across specialty pharmacies, hubs, patient support programs, and other external sources of safety information
  • Build strong partnerships with international stakeholders and external service providers to support consistent, high-quality execution across markets
  • Drive operational performance through meaningful KPIs, quality metrics, governance, and continuous improvement
  • Lead development and maintenance of functional SOPs, procedures, and other operational standards
  • Partner with Safety Systems to advance technology, automation, data integration, and digital capabilities supporting postmarketing safety
  • Partner with PV Compliance, Business Operations, and Quality on the implementation of standards, training, audits, inspections, and operational readiness
  • Partner with QPPVs to support effective international PV operations and oversight
  • Support postmarketing safety readiness for regulatory submissions, inspections, product launches, and lifecycle activities
  • Build organizational capabilities, develop talent, and foster a culture of accountability, collaboration, and quality
  • Serve as a key member of the PSPV Leadership Team and contribute to broader PSPV strategy and organizational growth

Preferred Skills, Qualifications and Technical Proficiencies

  • Bachelor's degree in pharmacy, nursing, or related discipline; advanced degree preferred
  • 14+ years of patient safety/pharmacovigilance experience in pharmaceutical or biotechnology, with significant experience in postmarketing safety
  • Strong leadership experience across global postmarketing safety operations, including ICSR case management and external safety-data channels
  • Demonstrated experience leading global or geographically distributed teams and managing international vendors and service providers
  • Strong understanding of global pharmacovigilance regulations, ICSR requirements, and postmarketing safety practices
  • Experience building and scaling operating models, processes, and teams in a growing pharmaceutical or biotechnology organization
  • Strong cross-functional leadership and ability to influence across functions, geographies, and external organizations
  • Demonstrated strategic thinking, operational excellence, and ability to lead through growth, change, and increasing organizational complexity

Requirements

  • Bachelor's degree in pharmacy, nursing, or related discipline
  • 14+ years of patient safety/pharmacovigilance experience in pharmaceutical or biotechnology
  • Significant experience in postmarketing safety
  • Strong leadership experience across global postmarketing safety operations, including ICSR case management and external safety-data channels
  • Demonstrated experience leading global or geographically distributed teams and managing international vendors and service providers
  • Strong understanding of global pharmacovigilance regulations, ICSR requirements, and postmarketing safety practices
  • Experience building and scaling operating models, processes, and teams in a growing pharmaceutical or biotechnology organization
  • Strong cross-functional leadership and ability to influence across functions, geographies, and external organizations
  • Demonstrated strategic thinking, operational excellence, and ability to lead through growth, change, and increasing organizational complexity

Company overview

Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company founded in 1998 and headquartered in Redwood City, California. The company specializes in the discovery, development, and commercialization of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Corcept's primary focus is on addressing the adverse effects of excess cortisol, which can lead to life-threatening conditions including Cushing's syndrome, various cancers, diabetes, and neurological disorders. The company's flagship product is Korlym (mifepristone), the first FDA-approved oral therapy for treating hyperglycemia in adult patients with endogenous Cushing's syndrome who have type 2 diabetes or glucose intolerance. With approximately 500 employees, Corcept has developed a large portfolio of proprietary compounds that selectively modulate cortisol effects without compromising progesterone function. The company maintains extensive intellectual property covering its selective cortisol modulators and continues to advance clinical trials for potential treatments of hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.